These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 35575140)

  • 1. Ratiometric fluorescent probe: a sensitive and reliable reporter for the CRISPR/Cas12a-based biosensing platform.
    Liu Q; Liu M; Jin Y; Li B
    Analyst; 2022 May; 147(11):2567-2574. PubMed ID: 35575140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensing platform for nucleic-acid detection based on a 2-aminopurine probe sheared by trans-cleavage activity of the CRISPR/Cas12a system.
    Chen X; Huang C; Hu Q; Zhang J; Wang D; You Q; Hu M
    Analyst; 2023 May; 148(11):2482-2492. PubMed ID: 37159025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRETting about CRISPR-Cas Assays: Dual-Channel Reporting Lowers Detection Limits and Times-to-Result.
    Lesinski JM; Khosla NK; Paganini C; Verberckmoes B; Vermandere H; deMello AJ; Richards DA
    ACS Sens; 2024 Jul; 9(7):3616-3624. PubMed ID: 38978209
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of Tetracycline with a CRISPR/Cas12a Aptasensor Using a Highly Efficient Fluorescent Polystyrene Microsphere Reporter System.
    Yee BJ; Zakaria SNA; Chandrawati R; Ahmed MU
    ACS Synth Biol; 2024 Jul; 13(7):2166-2176. PubMed ID: 38866727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ratiometric fluorescent biosensing platform for ultrasensitive detection of Salmonella typhimurium via CRISPR/Cas12a and silver nanoclusters.
    Ma L; Wang J; Li Y; Liao D; Zhang W; Han X; Man S
    J Hazard Mater; 2023 Feb; 443(Pt B):130234. PubMed ID: 36372024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratiometric CRISPR/Cas12a-Triggered CHA System Coupling with the MSRE to Detect Site-Specific DNA Methylation.
    Ding L; Cao S; Qu C; Wu Y; Yu S
    ACS Sens; 2024 Apr; 9(4):1877-1885. PubMed ID: 38573977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upconversion-mediated CRISPR-Cas12a biosensing for sensitive detection of ochratoxin A.
    Mao Z; Wang X; Chen R; Zhou Z; Ren S; Liang J; Gao Z
    Talanta; 2022 May; 242():123232. PubMed ID: 35180538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel label-free universal biosensing platform based on CRISPR/Cas12a for biomarker detection.
    Mu X; Wang X; Qin Y; Huang Y; Tian J; Zhao S
    Talanta; 2023 Jan; 251():123795. PubMed ID: 35952502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas12a Coupled with DNA Nanosheet-Amplified Fluorescence Anisotropy for Sensitive Detection of Biomolecules.
    Xie TJ; Xie JL; Luo YJ; Mao K; Huang CZ; Li YF; Zhen SJ
    Anal Chem; 2023 May; 95(18):7237-7243. PubMed ID: 37120835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "RESET" Effect: Random Extending Sequences Enhance the Trans-Cleavage Activity of CRISPR/Cas12a.
    Ma JY; Wang SY; Du YC; Wang DX; Tang AN; Wang J; Kong DM
    Anal Chem; 2022 Jun; 94(22):8050-8057. PubMed ID: 35615910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of DNA Target Formulations by CRISPR-Cas12a Using a dsDNA Reporter.
    Smith CW; Kachwala MJ; Nandu N; Yigit MV
    ACS Synth Biol; 2021 Jul; 10(7):1785-1791. PubMed ID: 34142793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasensitive, rapid, and highly specific detection of microRNAs based on PER-CRISPR/CAS.
    Wang Z; Wei H; Bu S; Li X; Zhou H; Zhang W; Wan J
    Bioorg Med Chem Lett; 2022 Oct; 74():128949. PubMed ID: 35998847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer assisted CRISPR-Cas12a strategy for small molecule diagnostics.
    Niu C; Wang C; Li F; Zheng X; Xing X; Zhang C
    Biosens Bioelectron; 2021 Jul; 183():113196. PubMed ID: 33839534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-triplex: A new type of CRISPR-Cas12a reporter enabling highly sensitive nucleic acid detection.
    Li T; Hu R; Xia J; Xu Z; Chen D; Xi J; Liu BF; Zhu J; Li Y; Yang Y; Liu M
    Biosens Bioelectron; 2021 Sep; 187():113292. PubMed ID: 33991961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controllable crRNA Self-Transcription Aided Dual-Amplified CRISPR-Cas12a Strategy for Highly Sensitive Biosensing of FEN1 Activity.
    Song Y; Gao K; Cai X; Cheng W; Ding S; Zhang D; Deng S
    ACS Synth Biol; 2022 Nov; 11(11):3847-3854. PubMed ID: 36240131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AND Logic-Gate-Based CRISPR/Cas12a Biosensing Platform for the Sensitive Colorimetric Detection of Dual miRNAs.
    Gong S; Wang X; Zhou P; Pan W; Li N; Tang B
    Anal Chem; 2022 Nov; 94(45):15839-15846. PubMed ID: 36318504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Trans-Cleavage Activity of CRISPR/Cas12a on Gold Nanoparticles for Stable and Sensitive Biosensing.
    Fu X; Shi Y; Peng F; Zhou M; Yin Y; Tan Y; Chen M; Yin X; Ke G; Zhang XB
    Anal Chem; 2021 Mar; 93(11):4967-4974. PubMed ID: 33703873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Supplying Guide RNA-Mediated CRISPR/Cas12a Fluorescence System for Sensitive Detection of T4 PNKP.
    Yuan X; Yuan H; Liu B; Liu Y
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Label-Free and Universal CRISPR/Cas12a-Based Detection Platform for Nucleic Acid Biomarkers.
    Zhao R; Xiao Y; Tang Y; Lu B; Li B
    ACS Sens; 2024 Sep; 9(9):4803-4810. PubMed ID: 39283984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing CRISPR-Cas12a Nuclease Activity Using Double-Stranded DNA-Templated Fluorescent Substrates.
    Smith CW; Nandu N; Kachwala MJ; Chen YS; Uyar TB; Yigit MV
    Biochemistry; 2020 Apr; 59(15):1474-1481. PubMed ID: 32233423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.